Highbridge Capital Management
ESLAW icon

Highbridge Capital Management’s Estrella Immunopharma Warrant ESLAW Stock Holding History

Highbridge Capital Management’s Portfolio ESLAW Stock Details ESLAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Hold
0
– – – 200
2024
Q4 		– Hold
0
– – – 264
2024
Q3 		– Hold
0
– – – 270
2024
Q2 		– Hold
0
– – – 294
2024
Q1 		– Hold
0
– – – 266
2023
Q4 		– Hold
0
– – – 293
2023
Q3 		– Hold
0
– – – 265

Other funds holding ESLAW

Boothbay Fund Management
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SkyView Investment Advisors
SkyView Investment Advisors Shrewsbury, New Jersey $128M AUM 19.21% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
Yakira Capital Management
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
Whitebox Advisors
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return
Clear Street
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
Landscape Capital Management
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return